Wilson I. Gonsalves, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Wilson I. Gonsalves, MD

Wilson I. Gonsalves, MD

Healthcare Professional
Consultant
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Wilson I. Gonsalves is a graduate from Creighton University and has also obtained a degree in medicine from Creighton University School of Medicine. He obtained clinical fellowship in 2015 from Mayo Clinic Rochester. Dr. Gonsalves mainly treats these conditions: amyloidosis, leukemia, monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell disorders.

Dr. Gonsalves focuses his research on understanding the cellular metabolism of malignant plasma cells in diseases such as multiple myeloma by employing a variety of systems biology techniques in an integrated fashion. His research interests are plasma cell neoplasms (multiple myeloma, plasma cell leukemia), light-chain amyloidosis, other monoclonal gammopathy related disorders, tumor metabolism, etc.

Dr. Gonsalves is interested in improving the supportive care of patients with plasma cell disorders by incorporating clinical interventions to improve symptoms and quality of life. He also studies population-based outcomes in various plasma cell disorders to identify trends and disparities in survival and utilization of therapies.

 

Representative Publications:

Palliative chemotherapy: an outdated term for life-prolonging systemic therapies for incurable malignancies

Effects of volume and site of blood draw on blood culture results 

A 49-year-old woman with acute respiratory failure 

Targeted anti-cancer therapy in the elderly 

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close